Centene pays $a hundred sixty five.6 million to settle allegations that its former pharmacy revenue supervisor overcharged the Texas Medicaid program for treatment.
Centene did not admit authorized accountability for violating the Texas Medicaid Fraud Prevention Act and maintains that its enterprise practices had been lawful, legal professional frequent Ken Paxton said in a information launch Monday.
The legal professional frequent’s office did not immediately reply to interview requests.
The insurer has paid elevated than $553 million to settle associated allegations from attorneys frequent in at the least eleven states: Texas, Arkansas, lllinois, Kansas, Louisiana, Mississippi, Nevada, New Hampshire, New Mexico, Ohio and Washington. California regulators are additionally investigating Centene over associated fraud claims.
The nation’s largest Medicaid managed care group has reserved an whole of $1.25 billion to resolve fraud allegations associated to its now-defunct Envolve PBM.
the agency exited the pharmacy enterprise earlier this yr when it purchased MagellanRx and PANTHERx unusual in separate transactions collectively valued at $2.eight billion. By the extreme of 2022, the insurer plans to finalize a contract with an out of doorways PBM to handle its $forty billion in annual pharmaceutical spending.